Covaxin trials for kids in India: Here's all you need to know
- 3 years ago
The screening of children for the trial of Covaxin, India’s first indigenously developed Covid-19 vaccine, among those aged between 2 and 18 started at the AIIMS Delhi on Monday.
The trial on children has already begun at AIIMS Patna to determine whether the Bharat Biotech jab is suitable for children. After receiving their screening results, participants would be given the vaccine. Meanwhile, The trial will involve 525 healthy volunteers.
The trial on children has already begun at AIIMS Patna to determine whether the Bharat Biotech jab is suitable for children. After receiving their screening results, participants would be given the vaccine. Meanwhile, The trial will involve 525 healthy volunteers.